Mechanisms of antimicrobial resistance: Their clinical relevance in the new millennium

Drugs

Volumn 62, Issue 4, 2002, Pages 557-566

  Sefton, Armine M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; ETHAMBUTOL; FOLIC ACID; ISONIAZID; MACROLIDE; METRONIDAZOLE; NALIDIXIC ACID; NYSTATIN; PENICILLIN DERIVATIVE; POLYMYXIN; QUINOLONE DERIVATIVE; RIFAMPICIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CELL WALL; BACTERIAL MEMBRANE; CELL MEMBRANE PERMEABILITY; ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS INFLUENZAE; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEIC ACID METABOLISM; REVIEW; SALMONELLA; SHIGELLA; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; NEISSERIA; NEISSERIA GONORRHOEAE; SALMONELLA; SHIGELLA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036207167     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262040-00001     Document Type: Review

References (34)

1. Antibiotic sensitivity testing
2. Resistance
3. Methicillin resistance in staphylococci: Molecular and biochemical basis and clinical implications
4. Multiplex PCR detection of vanA, vanB, vanC-2 and vanC-2/3 genes in enterococci
5. Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci
6. Mutations in the rpoB gene of rifampin resistance Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line assay
7. Mechanisms of fluoroquinolone resistance; an update 1994-1996
8. Mechanisms of acquired resistance
9. Of Pseudomonas, porins, pumps and carbapenems
10. Evolution epidemiology of MLS resistance
11. Molecular bacteriology: A diagnostic tool for the millennium
12. Molecular epidemiology in the care of patients
13. Quantitative molecular virology in patient management
14. The problem of resistance
15. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland
16. Persistence of sulphonamide resistance in Escherichia coli in the UK despite prescribing restriction
17. Why are antibiotic resistance genes so resistant to elimination?
18. Infection and antimicrobial prescribing control in the new millennium: Nightmare or nirvana?
19. A prospective study of risk factors for symptomatic urinary tract infection in young women
20. Are routine sensitivity data suitable for the surveillance of resistance? Resistance rates among Escherichia coli from blood and CSF from 1991-1997 as assessed by routine and centralised testing
21. Latest susceptibility data from the international study of bacterial pathogens from community acquired lower respiratory tract infections
22. Global surveillance for antituberculosis drug resistance, 1994-1997
23. Antibiotic resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona
24. Antimicrobial resistance in developing countries
25. Antimicrobial agents and gonorrhoea: Therapeutic choice, resistance and susceptibility testing
26. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from Latin American patients with a diagnosis of pneumonia: Results from the SENTRY antimicrobial surveillance program
27. Antimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997-1998
28. Bacterial pathogens isolated from patients with blood stream infections: Frequencies of occurrence and antimicrobial susceptibility patterns form SENTRY Antimicrobial Surveillance Programme (United States and Canada, 1997)
29. Surveillance of antibioti resistance in European ICUs
30. Role of the clinical microbiology laboratory in infection control a Danish perspective
31. Influence of serious infections due to Gram-negative bacteria on the hospital economy